GV

GeezerVison

The World Wide Web, restored to 800 pixels of glory.

Home|About|Gaming cabinet|Archives|How it works|Starter sites

On this site

  • Sign in
  • ActionsCI/CD and automation
  • CodespacesCloud development environments
  • All Features
  • Documentation
  • Training
  • Certifications
  • Build with Copilot
  • Customize Copilot
  • Integrations
  • Trending repos
  • GitHub Sponsors
  • Developer articles
  • Enterprises

This view

  • Original page
  • New address

GeezerVison is showing github.com — GitHub - Samuelson777/Glioblastoma-GBM-2026-The-Mechanical-Immunological-Axis: Research & Python models for the 2026 GBM study. Features the "Mechanical-Immunological Axis" (FUS + mRNA vaccines), Kaplan-Meier survival analysis, and clinical decision algorithms for precision neuro-oncology.

BranchesTags
Open more actions menu

Latest commit

 

History

9 Commits
9 Commits

Folders and files

NameName
Last commit message
Last commit date
Glioblastoma Research.pdf
Glioblastoma Research.pdf
 
 
Glioblastoma_Research_2026_Samuelson_G.pdf
Glioblastoma_Research_2026_Samuelson_G.pdf
 
 
LICENSE
LICENSE
 
 
README.md
README.md
 
 

Repository files navigation

Glioblastoma (GBM) 2026: The Mechanical-Immunological Axis

DOI License: CC BY 4.0

This repository contains the research manuscript for the paper: "Multi-Omic Integration and Therapeutic Frontiers in Glioblastoma Multiforme: A Systematic Review (2020–2026)."

📌 Project Overview

Traditional GBM treatments have reached a plateau. This research evaluates a novel synergy:

  • Mechanical: Focused Ultrasound (FUS) to breach the Blood-Brain Barrier (BBB).

  • Biological: Personalized mRNA neoantigen vaccines.

📊 Key Findings

  • Survival Impact: Meta-analysis of 2025 cohorts shows a statistically significant improvement in Progression-Free Survival (HR=0.64, p < 0.05) when using FUS-augmented delivery.

  • Ethics: Proposes a "Cognitive-First" framework, shifting the primary endpoint from survival duration to executive function preservation.

🏁 Conclusion

The research concludes that the "one-size-fits-all" approach to Glioblastoma is obsolete. By 2026, the integration of Mechanical (FUS) and Immunological (mRNA) therapies offers the first significant survival breakthrough in decades. However, success is not solely measured by months added to life, but by the preservation of the patient's "self" and cognitive autonomy. This paper serves as a roadmap for the ethical implementation of these high-cost, high-tech interventions in a way that prioritizes patient dignity.

📄 License

This work is licensed under a Creative Commons Attribution 4.0 International License.

✍️ AuthorsLead

Researcher: SAMUELSON G

About

Research & Python models for the 2026 GBM study. Features the "Mechanical-Immunological Axis" (FUS + mRNA vaccines), Kaplan-Meier survival analysis, and clinical decision algorithms for precision neuro-oncology.

Topics

bioethicsbrain-cancerfocused-ultrasoundglioblastomamedical-researchmrna-vaccinesneuro-oncologyprecision-medicinepython-sciencesurvival-analysis

Resources

Readme
MIT license
Activity

Stars

0 stars

Watchers

0 watching

Forks

0 forks
Report repository

Releases

Packages

Contributors

You are visitor 01402639 — GeezerVison does not store the pages you look up.
Best viewed with Netscape Navigator 4.7 or Internet Explorer 6 at 800×600. No cookies required.